South Korea Companion Diagnostics Market Size, Share, Trends and Forecast by Product and Service, Technology, Indication, End User, and Region, 2026-2034

July 2026 | 115 pages | ID: S5E5C6674B85EN
IMARC Group

Abstracts

The South Korea companion diagnostics market size reached USD 162.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 449.5 Million by 2034, exhibiting a growth rate (CAGR) of 11.62% during 2026-2034. The governing body is supporting the growth of companion diagnostics market through strategic healthcare reforms, subsidies, and investments in biotechnology. Additionally, the rise of telemedicine and digital health solutions, which is enhancing accessibility, enabling remote consultations and diagnostics, and expanding the reach of personalized healthcare services, is increasing the South Korea companion diagnostics market share.

SOUTH KOREA COMPANION DIAGNOSTICS MARKET TRENDS:

Government Initiatives and Healthcare Reforms

The governing authority in South Korea is pivotal in influencing the domestic companion diagnostics market via strategic healthcare reforms and investments in innovation. Due to a swiftly aging populace and rising healthcare needs, the governing body is emphasizing the incorporating advanced diagnostic technologies into the country’s medical system. To speed up the use of advanced technologies, the governing body is introducing subsidies, favorable reimbursement policies, and cultivated public-private partnerships (PPP). These efforts not only facilitate the regulatory approval process but also enhance the accessibility of companion diagnostics to a broader patient population. Additionally, rising investment in biotechnology and healthcare research, fostering a conducive environment for the creation and commercialization of diagnostic solutions. A significant instance is the declaration in 2024, when the Ministry of Science and ICT disclosed a ?2.2 trillion ($1.59 billion) allocation for healthcare R&D. This investment focused on sectors, such as mental health, welfare for the elderly and disabled, and fertility treatments, aiming to enhance South Korea’s position in the international bio sector. By supporting these initiatives, the governing authority is advocating for affordable, high-quality healthcare options that directly correspond with the growing need for personalized, precision-focused diagnostics. These initiatives are contributing to the South Korea companion diagnostics market growth, positioning the country as a key contributor to worldwide healthcare innovation.

Growth in Telemedicine and Remote Diagnostics

The emergence of telehealth platforms and digital health solutions is transforming healthcare services in South Korea, allowing companion diagnostics to reach a wider audience. Healthcare providers are progressively delivering remote consultations and diagnostic services, especially for patients in rural or underserved regions. Transitioning to digital health facilitates improved management of patient information and supports remote oversight, offering tailored treatment suggestions grounded in diagnostic outcomes. Integrating companion diagnostics with telemedicine systems allows healthcare professionals to work remotely with patients to analyze test results and modify treatments, improving the overall patient experience. This trend is additionally backed by the robust telemedicine sector in South Korea, which attained USD 1,744.4 million in 2024. With the rise of telehealth services, access to companion diagnostics is significantly increasing, allowing patients to avoid traveling to specialized centers for diagnostic testing or consultations. This accessibility enhances convenience and also facilitates the broader utilization of companion diagnostics, accelerating their adoption nationwide. As telemedicine evolves into an essential element of healthcare systems, particularly in rural regions, companion diagnostics are becoming more important, aiding the nation’s shift toward more tailored and efficient healthcare approaches.

SOUTH KOREA COMPANION DIAGNOSTICS MARKET SEGMENTATION:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product and service, technology, indication, and end user.

Product and Service Insights:

• Assays, Kits, and Reagents
• Software and Services

The report has provided a detailed breakup and analysis of the market based on the product and service. This includes assays, kits, and reagents and software and services.

Technology Insights:

• Immunohistochemistry (IHC)
• Polymerase Chain Reaction (PCR)
• In-situ Hybridization (ISH)
• Real-time PCR (RT-PCR)
• Gene Sequencing
• Others

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes immunohistochemistry (IHC), polymerase chain reaction (PCR), in-situ hybridization (ISH), real-time PCR (RT-PCR), gene sequencing, and others.

Indication Insights:

• Cancer
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Melanoma
• Others
• Neurological Diseases
• Infectious Diseases
• Cardiovascular Diseases

The report has provided a detailed breakup and analysis of the market based on the indication. This includes cancer (lung cancer, breast cancer, colorectal cancer, gastric cancer, melanoma, and others), neurological diseases, infectious diseases, cardiovascular diseases, and others.

End User Insights:

• Pharmaceutical and Biopharmaceutical Companies
• Reference Laboratories
• Contract Research Organizations

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pharmaceutical and biopharmaceutical companies, reference laboratories, contract research organizations, and others.

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and others.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea companion diagnostics market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea companion diagnostics market on the basis of product and service?
What is the breakup of the South Korea companion diagnostics market on the basis of technology?
What is the breakup of the South Korea companion diagnostics market on the basis of indication?
What is the breakup of the South Korea companion diagnostics market on the basis of end user?
What is the breakup of the South Korea companion diagnostics market on the basis of region?
What are the various stages in the value chain of the South Korea companion diagnostics market?
What are the key driving factors and challenges in the South Korea companion diagnostics market?
What is the structure of the South Korea companion diagnostics market and who are the key players?
What is the degree of competition in the South Korea companion diagnostics market?

Contents

1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 SOUTH KOREA COMPANION DIAGNOSTICS MARKET - INTRODUCTION

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 SOUTH KOREA COMPANION DIAGNOSTICS MARKET LANDSCAPE

5.1 Historical and Current Market Trends (?2020-2025?)
5.2 Market Forecast (?2026-2034?)

6 SOUTH KOREA COMPANION DIAGNOSTICS MARKET - BREAKUP BY PRODUCT AND SERVICE

6.1 Assays, Kits, and Reagents
  6.1.1 Overview
  6.1.2 Historical and Current Market Trends (?2020-2025?)
  6.1.3 Market Forecast (?2026-2034?)
6.2 Software and Services
  6.2.1 Overview
  6.2.2 Historical and Current Market Trends (?2020-2025?)
  6.2.3 Market Forecast (?2026-2034?)

7 SOUTH KOREA COMPANION DIAGNOSTICS MARKET - BREAKUP BY TECHNOLOGY

7.1 Immunohistochemistry (IHC)
  7.1.1 Overview
  7.1.2 Historical and Current Market Trends (?2020-2025?)
  7.1.3 Market Forecast (?2026-2034?)
7.2 Polymerase Chain Reaction (PCR)
  7.2.1 Overview
  7.2.2 Historical and Current Market Trends (?2020-2025?)
  7.2.3 Market Forecast (?2026-2034?)
7.3 In-situ Hybridization (ISH)
  7.3.1 Overview
  7.3.2 Historical and Current Market Trends (?2020-2025?)
  7.3.3 Market Forecast (?2026-2034?)
7.4 Real-time PCR (RT-PCR)
  7.4.1 Overview
  7.4.2 Historical and Current Market Trends (?2020-2025?)
  7.4.3 Market Forecast (?2026-2034?)
7.5 Gene Sequencing
  7.5.1 Overview
  7.5.2 Historical and Current Market Trends (?2020-2025?)
  7.5.3 Market Forecast (?2026-2034?)
7.6 Others
  7.6.1 Historical and Current Market Trends (?2020-2025?)
  7.6.2 Market Forecast (?2026-2034?)

8 SOUTH KOREA COMPANION DIAGNOSTICS MARKET - BREAKUP BY INDICATION

8.1 Cancer
  8.1.1 Overview
  8.1.2 Historical and Current Market Trends (?2020-2025?)
  8.1.3 Market Segmentation
    8.1.3.1 Lung Cancer
    8.1.3.2 Breast Cancer
    8.1.3.3 Colorectal Cancer
    8.1.3.4 Gastric Cancer
    8.1.3.5 Melanoma
    8.1.3.6 Others
  8.1.4 Market Forecast (?2026-2034?)
8.2 Neurological Diseases
  8.2.1 Overview
  8.2.2 Historical and Current Market Trends (?2020-2025?)
  8.2.3 Market Forecast (?2026-2034?)
8.3 Infectious Diseases
  8.3.1 Overview
  8.3.2 Historical and Current Market Trends (?2020-2025?)
  8.3.3 Market Forecast (?2026-2034?)
8.4 Cardiovascular Diseases
  8.4.1 Overview
  8.4.2 Historical and Current Market Trends (?2020-2025?)
  8.4.3 Market Forecast (?2026-2034?)
8.5 Others
  8.5.1 Historical and Current Market Trends (?2020-2025?)
  8.5.2 Market Forecast (?2026-2034?)

9 SOUTH KOREA COMPANION DIAGNOSTICS MARKET - BREAKUP BY END USER

9.1 Pharmaceutical and Biopharmaceutical Companies
  9.1.1 Overview
  9.1.2 Historical and Current Market Trends (?2020-2025?)
  9.1.3 Market Forecast (?2026-2034?)
9.2 Reference Laboratories
  9.2.1 Overview
  9.2.2 Historical and Current Market Trends (?2020-2025?)
  9.2.3 Market Forecast (?2026-2034?)
9.3 Contract Research Organizations
  9.3.1 Overview
  9.3.2 Historical and Current Market Trends (?2020-2025?)
  9.3.3 Market Forecast (?2026-2034?)
9.4 Others
  9.4.1 Historical and Current Market Trends (?2020-2025?)
  9.4.2 Market Forecast (?2026-2034?)

10 SOUTH KOREA COMPANION DIAGNOSTICS MARKET – BREAKUP BY REGION

10.1 Seoul Capital Area
  10.1.1 Overview
  10.1.2 Historical and Current Market Trends (?2020-2025?)
  10.1.3 Market Breakup by Product and Service
  10.1.4 Market Breakup by Technology
  10.1.5 Market Breakup by Indication
  10.1.6 Market Breakup by End User
  10.1.7 Key Players
  10.1.8 Market Forecast (?2026-2034?)
10.2 Yeongnam (Southeastern Region)
  10.2.1 Overview
  10.2.2 Historical and Current Market Trends (?2020-2025?)
  10.2.3 Market Breakup by Product and Service
  10.2.4 Market Breakup by Technology
  10.2.5 Market Breakup by Indication
  10.2.6 Market Breakup by End User
  10.2.7 Key Players
  10.2.8 Market Forecast (?2026-2034?)
10.3 Honam (Southwestern Region)
  10.3.1 Overview
  10.3.2 Historical and Current Market Trends (?2020-2025?)
  10.3.3 Market Breakup by Product and Service
  10.3.4 Market Breakup by Technology
  10.3.5 Market Breakup by Indication
  10.3.6 Market Breakup by End User
  10.3.7 Key Players
  10.3.8 Market Forecast (?2026-2034?)
10.4 Hoseo (Central Region)
  10.4.1 Overview
  10.4.2 Historical and Current Market Trends (?2020-2025?)
  10.4.3 Market Breakup by Product and Service
  10.4.4 Market Breakup by Technology
  10.4.5 Market Breakup by Indication
  10.4.6 Market Breakup by End User
  10.4.7 Key Players
  10.4.8 Market Forecast (?2026-2034?)
10.5 Others
  10.5.1 Historical and Current Market Trends (?2020-2025?)
  10.5.2 Market Forecast (?2026-2034?)

11 SOUTH KOREA COMPANION DIAGNOSTICS MARKET – COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 PROFILES OF KEY PLAYERS

12.1 Company A
  12.1.1 Business Overview
  12.1.2 Services Offered
  12.1.3 Business Strategies
  12.1.4 SWOT Analysis
  12.1.5 Major News and Events
12.2 Company B
  12.2.1 Business Overview
  12.2.2 Services Offered
  12.2.3 Business Strategies
  12.2.4 SWOT Analysis
  12.2.5 Major News and Events
12.3 Company C
  12.3.1 Business Overview
  12.3.2 Services Offered
  12.3.3 Business Strategies
  12.3.4 SWOT Analysis
  12.3.5 Major News and Events
12.4 Company D
  12.4.1 Business Overview
  12.4.2 Services Offered
  12.4.3 Business Strategies
  12.4.4 SWOT Analysis
  12.4.5 Major News and Events
12.5 Company E
  12.5.1 Business Overview
  12.5.2 Services Offered
  12.5.3 Business Strategies
  12.5.4 SWOT Analysis
  12.5.5 Major News and Events

13 SOUTH KOREA COMPANION DIAGNOSTICS MARKET - INDUSTRY ANALYSIS

13.1 Drivers, Restraints, and Opportunities
  13.1.1 Overview
  13.1.2 Drivers
  13.1.3 Restraints
  13.1.4 Opportunities
13.2 Porters Five Forces Analysis
  13.2.1 Overview
  13.2.2 Bargaining Power of Buyers
  13.2.3 Bargaining Power of Suppliers
  13.2.4 Degree of Competition
  13.2.5 Threat of New Entrants
  13.2.6 Threat of Substitutes
13.3 Value Chain Analysis

14 APPENDIX